CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)
Titel:
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)
Auteur:
Fietz, Simon Zarbl, Romina Niebel, Dennis Posch, Christian Brossart, Peter Gielen, Gerrit H. Strieth, Sebastian Pietsch, Torsten Kristiansen, Glen Bootz, Friedrich Landsberg, Jennifer Dietrich, Dimo